Leucine dehydrogenase mutant with improved catalytic activity and application of leucine dehydrogenase mutant
A technique for leucine dehydrogenase and mutants, applied in the field of leucine dehydrogenase mutants
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] Example 1: Expression of Leucine Dehydrogenase Wild Enzyme
[0038](1) Synthesize and obtain the leucine dehydrogenase whose coding nucleotide sequence is shown in SEQ ID NO.3.
[0039] (2) Construction and transformation of gene expression vector
[0040] The leucine dehydrogenase and the pET-28a vector with the coding nucleotide sequence shown in SEQ ID NO.3 are double-digested with restriction endonucleases BamH I and Hind III, and the products after digestion are ligated with Solution I and The ligation product was transformed into Escherichia coli BL21(DE3), and four transformants were picked to extract plasmids BamH I and Hind III for enzyme digestion verification to obtain recombinant Escherichia coli BL21 / pET-28a-LeuDH.
Embodiment 2
[0041] Embodiment 2: the preparation of leucine dehydrogenase mutant
[0042] Specific steps are as follows:
[0043] (1) Preparation of Leucine Dehydrogenase Mutants
[0044] Using the reverse PCR method of the whole plasmid, the oligonucleotide fragments with different numbers of amino acids excised from the C-terminal were designed as upstream and downstream primers for the homology arms, and the recombinant plasmid pET-28a-LeuDH obtained in Example 1 was used as a template to carry out the C-terminal excision transformation, Obtained the mutant carrying the encoding leucine dehydrogenase△ 364-374 , △ 369-374 , △ 373-374 Gene recombinant plasmids pET-28a-LeuDH1~pET-28a-LeuDH3;
[0045] Among them, the mutant △ 364-374 It is obtained by excising the C-terminal residue 364-arginine to 374-glycine with the leucine dehydrogenase shown in SEQ ID NO.1, and the primers used are as follows:
[0046] △ 364-374 -F: 5'-GACAGCAAATGGGTCGCGGATCCATGGTGGAAACCAATGTGGAAG-3' (SEQ ID NO...
Embodiment 3
[0058] Example 3: Expression of Leucine Dehydrogenase Mutants
[0059] The recombinant Escherichia coli BL21 / pET-28a-LeuDH prepared in Example 1 and Example 2 and the recombinant Escherichia coli BL21 / pET-28a-LeuDH1~pET-28a-LeuDH3 were respectively inoculated in LB containing 50 μg / mL kanamycin In the liquid medium, after culturing overnight at 37°C and 180r / min, inoculate 1% of the inoculum into 50mL LB medium, culture at 37°C, rotate at 180r / min, and cultivate until OD600 reaches 0.5-0.8 Then add IPTG with a final concentration of 0.5mM for induction, and the induction temperature is lowered to 25°C. After induction for 8-10h, 4°C, 8000rpm centrifuge for 10min to collect the bacterial cells, take the collected wet bacterial cells, and use 5mL of 50mM pH 7.5 Wash twice with PBS buffer, resuspend in 5mL of 50mM PBS buffer with pH 7.5, oscillate and shake well, and then break under ultrasonic wave, break for 1s, stop for 3s, the total time is 15min. The cell lysate was centrif...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com